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546 Abstracts August 2014reliable device serving as the frozen elephant trunk to provide sufﬁcient
proximal anchor. Furthermore, the second stage with normal aortic
ﬂow allows for angiography-based deployment of the stent graft in the
aorta at its ideal distal anchoring site.
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Objective: Prior reports have suggested unfavorable outcomes after
endovascular aneurysm repair (EVAR) performed outside of the recommen-
ded instructions for use (IFU). We report our long-term EVAR experience
with regard to IFU in a large multicenter registry.
Methods: Between 2000 and 2010, 1736 patients underwent EVAR,
with 92% follow-up. Baseline anatomic measurements obtained from the
M2S Inc imaging database were compared with device-speciﬁc IFU. Pri-
mary outcomes were mortality and aneurysm-related mortality (ARM). Sec-
ondary outcomes were endoleak status, adverse events, and reintervention.
Results: During the median follow-up of 2.7 years, 489 patients
(28.2%) had preoperative anatomic data available. Overall, 58% had
EVAR performed within and 42% outside of IFU guidelines. Of the
outside-IFU patients, 62.4% had short neck length, 10.2% had greater angu-
lation, 7.3% did not meet neck diameter criteria, and 20% had multiple
anatomic issues. There was no difference in any of the primary or secondary
outcomes between the two groups (Table). The percentage change in
aneurysm sac size over time appeared similar (12.1% vs 14.1% at 5 years),
with no signiﬁcant difference in sac increase at any time point during follow-
up. Cox proportional hazard models showed that IFU nonadherence was
not predictive of overall mortality (hazard ratio [HR], 1.06; P ¼ .80), ARM
(HR, 0.17; P ¼ .07). or adverse events (HR, 0.84; P ¼ .61).
Conclusions: In our cohort of EVAR patients with detailed preop-
erative anatomic information and long-term follow-up, overall mortality
and ARM were unaffected by IFU adherence, despite a higher propor-
tion of women and larger aneurysms in the nonadherent group. In addi-
tion, rates of late endoleak and reintervention were similar, suggesting
that operator experience and patient selection inﬂuence outcomes despite
lack of IFU-based anatomic suitability.Table. Select demographics and outcomes by instructions for use (IFU)
status
Variable
IFU adherent
(n ¼ 284)
IFU nonadherent
(n ¼ 205) P
Female, % 6.7 14.6 <.01
Baseline AAA size, mm 56.6 59.7 <.01
Overall mortality, % 21.1 21.5 .93
ARM, % 2.8 1.0 .20
Type I/III leak, % 3.5 4.4 .62
Adverse events, % 8.8 11.2 .38
Reintervention, % 13.4 17.6 .20
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Extended Proximal Seal Zone During EVAR Predicts Aneurysm Sac
Regression
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Cardiovascular Surgical Associates, Jackson, MissObjective: The success of endovascular aneurysm repair (EVAR) is
often stratiﬁed in terms of proximal neck morphology. Irrespective of tradi-
tional aortic neck deﬁnitions, detailed imaging analysis of endograft-aortic
wall apposition may elucidate the effect of the seal zone extension on aneu-
rysm-related outcomes.
Methods: Core laboratory analysis of computed tomography (CT)
scans was performed in 41 patients undergoing EVAR with the AFX endog-
raft (Endologix, Irvine, Calif). AFX incorporates highly conformable
expanded polytetraﬂuoroethylene material external to the stent frame, mov-
ing independently to facilitate endograft-aortic wall apposition (ActiveSeal).
Aortic neck length was deﬁned as the infrarenal aortic length where the
aortic diameter remained within 10% of infrarenal reference. The effective
seal length and apposition surface area were determined based on the area
with 360o apposition between the graft material and the aortic wall. The
Pearson coefﬁcient was calculated between anatomic variables and the
amount of sac regression. Values are expressed as mean 6 standard
deviation.
Results: After implantation, the endograft was circumferentially
apposed to the aortic wall over a mean length of 28 6 17 mm, aver-
aging 5 mm more than the aortic neck length. By using standard deﬁ-
nition and during 12 6 5 months of follow-up, 98% of patients
exhibited sac regression or stabilization. Sac regression was positively
correlated with effective seal length (P < .05) and apposition surface
area (P < .05). Trends toward reduced sac regression in larger aneu-
rysms did not attain statistical signiﬁcance (P ¼ .075). Sac regression
was not associated with aortic neck length, diameter, angulation, or
thrombus/calcium composition.
Conclusions: Sac regression during EVAR using the AFX endograft
with ActiveSeal appears to correlate with the effective seal length and the
surface area of circumferential apposition between the aorta and the graft
material. When effective seal length and apposition are considered, tradi-
tional anatomic variables are not associated with aneurysm sac outcomes.
The ability of ActiveSeal to extend effective seal length beyond the anatomic
neck may constitute an additional consideration in planning of EVAR
procedures.
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Objective: Despite being rare (<0.7% population), renal artery aneu-
rysms (RAAs) represent the second most common visceral artery aneurysm
but have a relatively poorly understood natural history. Open surgery can be
extensive and usually involves ex vivo techniques, particularly because most
RAAs are in the distal renal artery or branch points. Endovascular repair of
RAAs can be technically challenging, depending on the branch point anat-
omy. We report a case of successful endovascular exclusion of two large
adjacent RAAs in a patient, which were unusually located in the proximal
renal artery.
Methods: A 68-year-old man with vague intermittent abdominal
discomfort was found incidentally to have two large proximal RAAs
measuring 5.4 cm and 3.9 cm (Fig). The larger, more distal aneurysm
was thrombosed, whereas the smaller, more proximal aneurysm came off
just distal to the renal ostium and was ﬁlling.
Results: The RAAs were successfully excluded after overlapping
placement of a 7-mm  50-mm Viabahn covered stent placed in the middle
to distal right renal artery from a femoral approach and a subsequent 7-mm
 38-mm iCAST covered stent protruding slightly into the aortic lumen
from a brachial approach. There were no postoperative complications, and
he has since been maintained on dual antiplatelet therapy. At the 2-year
follow-up, he remains asymptomatic, and imaging continues to demonstrate
exclusion and regression of both RAAs as well as normal renal arterial
perfusion.
Conclusions: Endovascular repair of RAAs via exclusion with covered
stents is a safe and effective therapeutic option when such aneurysms are
limited to the proximal or midportion of the renal artery. A brachial artery
approach is often required in such cases due to signiﬁcant renal artery tor-
tuosity or downward angulation.
Table. Effect of preoperative cardiac stress testing (CST) on outcomes
after open or endovascular abdominal aortic aneurysm repair
Outcomes (CST vs no CST) OR (95% CI) P
30-day
Myocardial infarction 1.16 (0.71-1.92) .55
MACE 1.15 (0.89-1.49) .28
Mortality 0.70 (0.44-1.10) .12
MACE or mortality 1.03 (0.82-1.29) .82
1-year mortality 0.99 (0.69-1.41) .95
CI, Conﬁdence interval; MACE, major adverse cardiac event; OR, odds
ratio.
Fig. Preoperative computed tomographic angiography demonstrating two
large proximal right renal artery aneurysms (A-B). Angiography following
placement of initial covered stent in proximal-mid right renal artery (C). Given
persistent ﬁlling of the more proximal aneurysm, a brachial approach was used
to place a second, more proximal covered stent (D). Postoperative imaging
demonstrating successful aneurysm exclusion and absence of endoleak at two-
week (E-F), one-year (G), and two-year (H) follow-up periods.
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Cardiac Stress Testing During Workup for Abdominal Aortic
Aneurysm Repair Does Not Improve Patient Outcomes
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Objective: Cardiac stress testing (CST) is commonly used to help
determine whether patients with abdominal aortic aneurysms (AAAs) are
candidates for open (oAAA) vs endovascular repair (EVAR), although it is
unknown whether CST achieves its goal of optimizing patient selection
and postoperative outcomes. This study examined whether use of CST im-
proves adverse cardiac events and survival after AAA repair.
Methods: We identiﬁed 3635 patients in the Vascular Quality Initia-
tive (VQI) database (2010-2012) with an AAA $5.0 cm who were candi-
dates for oAAA or EVAR. The VSG Cardiac Risk Index was used to stratify
patient risk. We then applied generalized estimating equations with inverse
probability weighting to adjust for patient factors and hospital level CSTutilization to evaluate the effect of CST on 30-day major adverse cardiac
events and mortality after AAA repair. Analyses were restricted to hospitals
with 20% to 80% CST utilization to facilitate adjustment of the utilization
rate.
Results: CST was used in 1627 patients (45%) during AAA workup,
including 451 of 794 patients (57%) selected for oAAA and 1176 of
2841 patients (41%) selected for EVAR. After inverse probability weighting,
the use of CST was not associated with the proportion of patients receiving
oAAA vs EVAR (odds ratio, 1.00; 95% conﬁdence interval, 0.77-1.32).
Compared with patients without CST during the AAA workup, adjusted an-
alyses revealed that CST utilization was not associated with improved out-
comes after AAA repair (Table). Among patients receiving CST, an
abnormal CST was not signiﬁcantly associated with selection of oAAA vs
EVAR or with postoperative outcomes after adjustment for the VSG cardiac
risk score.
Conclusions: Utilization of CST during workup for AAA repair is not
associated with improved postoperative outcomes. Our results suggest that
CST adds no value beyond known clinical risk factors when selecting pa-
tients for oAAA vs EVAR or in predicting postoperative cardiac events.Author Disclosures: B. S. Brooke: None; Y. Zhang: None; T. H.
Greene: None; Y. Zhang: None; A. Presson: None; L. W. Kraiss: None.
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Objective: Fenestrated endovascular aortic stent grafts (FEVAR) are
high radiation dose cases, yet no skin injuries were found retrospectively
in our 61 cases with a mean peak skin dose (PSD) of 6.8 Gy. We hypothe-
size that skin injury is under-reported. This study examined the determin-
istic effects in FEVARs after procedural changes implemented to detect
skin injury.
Methods: All procedures with a radiation dose >5 Gy reference air
kerma (RAK; NCRP threshold for substantial radiation dose level
[SRDL]) were included during a 6-month period. Patients were questioned
about skin erythema, epilation, and necrosis, with a physical examination of
the back completed daily until discharge and then at 2 weeks, 4 weeks, and
3 months. PSD distributions were calculated using custom software using
input data from ﬂuoroscopic machine logs and were validated against gaf-
chromic ﬁlm measurements using linear regression. Dose was summed for
the subset of patients with multiple procedures within 6 months of the
SRDL event, consistent with TJC recommendations.
Results: Twenty-two cases reached a RAK of 5 Gy. The average RAK
was 7.6 6 1.9 Gy (range, 5.1-11.4 Gy), and the mean PSD was 5.9 6 1.5
Gy (range, 4.0-8.9 Gy). Fifty-ﬁve percent had had multiple endovascular
procedures within 6 months of the SRDL event. The mean RAK for this
subset was 9.6 6 2.4 Gy (range, 5.5-13.4 Gy), and mean PSD was 6.2 6
2.0 Gy (range, 4.5-11.0 Gy). Gafchromic ﬁlm measurements were not
different from PSD estimations (P < .001), with a constant of proportion-
ality of 0.996 0.02. One patient died before the ﬁrst postoperative visit. No
radiation skin injuries were found. Putative risk factors for skin injury were
evaluated: Smoking (32%), diabetes (14%), cytotoxic drugs (9%), and fair
skin type (91%). No other risk factors were present (hyperthyroidism,
collagen vascular disorders).
Conclusions: Radiation doses in this study exceeded published
thresholds for cutaneous injury, yet no radiation skin injuries were observed.
This suggests that deterministic effects are likely less frequent than
